77 related articles for article (PubMed ID: 20622458)
1. Surface-displayed expression of a neutralizing epitope of ApxIIA exotoxin in Saccharomyces cerevisiae and oral administration of it for protective immune responses against challenge by Actinobacillus pleuropneumoniae.
Kim JM; Jung DI; Eom YJ; Park SM; Yoo HS; Jang YS; Yang MS; Kim DH
Biosci Biotechnol Biochem; 2010; 74(7):1362-7. PubMed ID: 20622458
[TBL] [Abstract][Full Text] [Related]
2. Induction of antigen-specific immune responses by oral vaccination with Saccharomyces cerevisiae expressing Actinobacillus pleuropneumoniae ApxIIA.
Shin SJ; Bae JL; Cho YW; Lee DY; Kim DH; Yang MS; Jang YS; Yoo HS
FEMS Immunol Med Microbiol; 2005 Feb; 43(2):155-64. PubMed ID: 15681145
[TBL] [Abstract][Full Text] [Related]
3. Oral immunization of mice with Saccharomyces cerevisiae expressing a neutralizing epitope of ApxIIA exotoxin from Actinobacillus pleuropneumoniae induces systemic and mucosal immune responses.
Shin MK; Lee WJ; Jung MH; Cha SB; Shin SW; Yoo A; Kim DH; Yoo HS
Microbiol Immunol; 2013 Jun; 57(6):417-25. PubMed ID: 23773020
[TBL] [Abstract][Full Text] [Related]
4. Induction of protective immune responses against challenge of Actinobacillus pleuropneumoniae by oral administration with Saccharomyces cerevisiae expressing Apx toxins in pigs.
Shin MK; Kang ML; Jung MH; Cha SB; Lee WJ; Kim JM; Kim DH; Yoo HS
Vet Immunol Immunopathol; 2013 Jan; 151(1-2):132-9. PubMed ID: 23206402
[TBL] [Abstract][Full Text] [Related]
5. Induction of protective immune responses against the challenge of Actinobacillus pleuropneumoniae by the oral administration of transgenic tobacco plant expressing ApxIIA toxin from the bacteria.
Lee KY; Kim DH; Kang TJ; Kim J; Chung GH; Yoo HS; Arntzen CJ; Yang MS; Jang YS
FEMS Immunol Med Microbiol; 2006 Dec; 48(3):381-9. PubMed ID: 17054716
[TBL] [Abstract][Full Text] [Related]
6. Nasal immunization with major epitope-containing ApxIIA toxin fragment induces protective immunity against challenge infection with Actinobacillus pleuropneumoniae in a murine model.
Seo KW; Kim SH; Park J; Son Y; Yoo HS; Lee KY; Jang YS
Vet Immunol Immunopathol; 2013 Jan; 151(1-2):102-12. PubMed ID: 23200821
[TBL] [Abstract][Full Text] [Related]
7. Functional pentameric formation via coexpression of the Escherichia coli heat-labile enterotoxin B subunit and its fusion protein subunit with a neutralizing epitope of ApxIIA exotoxin improves the mucosal immunogenicity and protection against challenge by Actinobacillus pleuropneumoniae.
Kim JM; Park SM; Kim JA; Park JA; Yi MH; Kim NS; Bae JL; Park SG; Jang YS; Yang MS; Kim DH
Clin Vaccine Immunol; 2011 Dec; 18(12):2168-77. PubMed ID: 22030372
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of protective immune responses by oral vaccination with Saccharomyces cerevisiae expressing recombinant Actinobacillus pleuropneumoniae ApxIA or ApxIIA in mice.
Shin SJ; Shin SW; Kang ML; Lee DY; Yang MS; Jang YS; Yoo HS
J Vet Sci; 2007 Dec; 8(4):383-92. PubMed ID: 17993753
[TBL] [Abstract][Full Text] [Related]
9. Characterization of antigenic determinants in ApxIIA exotoxin capable of inducing protective immunity to Actinobacillus pleuropneumoniae challenge.
Seo KW; Kim DH; Kim AH; Yoo HS; Lee KY; Jang YS
Immunol Invest; 2011; 40(5):465-80. PubMed ID: 21425909
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and protective efficacy of ApxIA and ApxIIA DNA vaccine against Actinobacillus pleuropneumoniae lethal challenge in murine model.
Chiang CH; Huang WF; Huang LP; Lin SF; Yang WJ
Vaccine; 2009 Jul; 27(34):4565-70. PubMed ID: 19520199
[TBL] [Abstract][Full Text] [Related]
11. Nasal immunization with mannan-decorated mucoadhesive HPMCP microspheres containing ApxIIA toxin induces protective immunity against challenge infection with Actinobacillus pleuropneumoiae in mice.
Li HS; Shin MK; Singh B; Maharjan S; Park TE; Kang SK; Yoo HS; Hong ZS; Cho CS; Choi YJ
J Control Release; 2016 Jul; 233():114-25. PubMed ID: 27189136
[TBL] [Abstract][Full Text] [Related]
12. Genetic and antigenic characteristics of ApxIIA and ApxIIIA from Actinobacillus pleuropneumoniae serovars 2, 3, 4, 6, 8 and 15.
To H; Nagai S; Iwata A; Koyama T; Oshima A; Tsutsumi N
Microbiol Immunol; 2016 Jul; 60(7):447-58. PubMed ID: 27211905
[TBL] [Abstract][Full Text] [Related]
13. Development of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae infection.
Maas A; Meens J; Baltes N; Hennig-Pauka I; Gerlach GF
Vaccine; 2006 Nov; 24(49-50):7226-37. PubMed ID: 17027123
[TBL] [Abstract][Full Text] [Related]
14. Production and immunogenicity of Actinobacillus pleuropneumoniae ApxIIA protein in transgenic rice callus.
Kim MY; Kim TG; Yang MS
Protein Expr Purif; 2017 Apr; 132():116-123. PubMed ID: 27215671
[TBL] [Abstract][Full Text] [Related]
15. Generation of transgenic corn-derived Actinobacillus pleuropneumoniae ApxIIA fused with the cholera toxin B subunit as a vaccine candidate.
Shin MK; Jung MH; Lee WJ; Choi PS; Jang YS; Yoo HS
J Vet Sci; 2011 Dec; 12(4):401-3. PubMed ID: 22122907
[TBL] [Abstract][Full Text] [Related]
16. DNA vaccine encoding type IV pilin of Actinobacillus pleuropneumoniae induces strong immune response but confers limited protective efficacy against serotype 2 challenge.
Lu YC; Li MC; Chen YM; Chu CY; Lin SF; Yang WJ
Vaccine; 2011 Oct; 29(44):7740-6. PubMed ID: 21835218
[TBL] [Abstract][Full Text] [Related]
17. A predictive model for the level of sIgA based on IgG levels following the oral administration of antigens expressed in Saccharomyces cerevisiae.
Shin SJ; Shin SW; Choi EJ; Lee DY; Ahn JM; Yang MS; Jang YS; Yoo HS
J Vet Sci; 2005 Dec; 6(4):305-9. PubMed ID: 16293994
[TBL] [Abstract][Full Text] [Related]
18. [Cloning and expression of hemolytic-toxin from Actinobacillus pleuropneumoniae and the immunoprotection in mice].
Du A; Diao Y; Zhang W; Zhang R; Zang D; Liu F
Wei Sheng Wu Xue Bao; 2008 Mar; 48(3):342-8. PubMed ID: 18479061
[TBL] [Abstract][Full Text] [Related]
19. [Construction and characterization of Actinobacillus pleuropneumoniae serovar 7 live attenuated vaccine strain co-expressing ApxIA].
Liu J; Chen Y; Hu L; Bei W; Chen H
Sheng Wu Gong Cheng Xue Bao; 2010 Mar; 26(3):305-10. PubMed ID: 20518341
[TBL] [Abstract][Full Text] [Related]
20. Potential use an Actinobacillus pleuropneumoniae double mutant strain DeltaapxIICDeltaapxIVA as live vaccine that allows serological differentiation between vaccinated and infected animals.
Liu J; Chen X; Lin L; Tan C; Chen Y; Guo Y; Jin M; Guo A; Bei W; Chen H
Vaccine; 2007 Nov; 25(44):7696-705. PubMed ID: 17767980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
